A poster on NeuroBo’s second candidate, NB-02, was presented at the Society for Neuroscience’s conference, Neuroscience 2018, during a session titled, “Alzheimer's Disease and Other Dementias: Therapeutic Strategies: Preclinical Cellular Models.” This study, conducted out of Massachusetts General Hospital and Harvard Medical School, shows that active properties in NB-02 demonstrated strong preventative effects of amyloid plaque. The study also concluded that NB-02 has great promise as a potential therapeutic for Alzheimer’s Disease.
Novel botanical drug DA-9803 prevents deficits in Alzheimer's mouse models. Alzheimers Res Ther. 2018 Jan 29;10(1):11. doi: 10.1186/s13195-018-0338-2. Pagnier GJ1, Kastanenka KV1, Sohn M2, Choi S2, Choi SH2, Soh H2, Bacskai BJ3.